ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

Acadia Pharma Slides Despite Positive Major Depressive Disorder Results

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares dipped on Wednesday despite the announcement of positive top-line results from its Clarity midstage study in major depressive disorder (MDD). In the trial, pimavanserin ...
Read Full Story »

What the FDA Has to Say About Acadia Pharma’s Parkinson’s Treatment

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares made a handy gain to close out the week after the company announced that the U.S. Food and Drug Administration (FDA) completed a post-marketing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Alcoa, AT&T, Darden, Micron, New Age Beverages, Nike, Novavax, Pier 1, Under Armour and More

Stocks were indicated marginally higher on Friday, but this as after the Dow Jones industrials and S&P 500 hit all-time high closes on Thursday. International markets were also higher on ...
Read Full Story »

Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018

Biotechnology companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single clinical trial could either ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Stocks were indicated to open lower on Thursday morning, though the S&P 500 hit an all-time high earlier in the week. Earnings season is all but over now and was ...
Read Full Story »

Coty, e.l.f Beauty Sink into Thursday’s 52-Week Low Club

August 9, 2018: Here are four stocks trading with heavy volume among 96 equities making new 52-week lows in Thursday's session. On the NYSE decliners and advancers traded even and ...
Read Full Story »

6 Stocks Defying the Bull Market With Multiple Analyst Downgrades and Price Target Cuts

The morning roll call of analyst upgrades and downgrades included about 20 companies this Thursday. There are many companies that are falling outside of the strong trends of this earnings ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Applied Materials, Extreme Networks, Mylan, NXP, Roku, Seagate, Yelp, Zynga and More

Stocks were indicated to open marginally higher after a weaker producer price index report calmed some inflation fears. Earnings season has been quite strong, with more than 70% of the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts, Zillow and More

Stocks were indicated to higher on Tuesday after Monday's recovery rally. Investors have seen a very strong earnings season, with 80% of the S&P 500 reporting earnings and over 70% ...
Read Full Story »

Mannkind, Tesaro Can’t Escape Monday’s 52-Week Low Club

August 6, 2018: Here are four stocks trading with heavy volume among 96 equities making new 52-week lows in Monday's session. On the NYSE advancers led decliners by about 1.44 ...
Read Full Story »

Coca-Cola, LendingClub Skid into Wednesday’s 52-Week Low Club

April 25, 2018: Here are four stocks trading with heavy volume among 136 equities making new 52-week lows in Wednesday's session. On the NYSE decliners led advancers by about 3 ...
Read Full Story »

Acadia, Incyte Show the Way to Monday’s 52-Week Low Club

April 9, 2018: Here are four stocks trading with heavy volume among 77 equities making new 52-week lows in Monday's session. On the NYSE advancers led decliners by more than ...
Read Full Story »

Analyst Has 4 Favorite Biotechnology Stocks to Buy Now

Biotechnology tends to have very strong up and down moves, and last year the industry reversed the down momentum that started in 2015 and actually outperformed the S&P 500. Many ...
Read Full Story »

Why Acadia Pharma Is One of Wednesday’s Best Earnings Reports

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) reported its second-quarter financial results after the markets closed on Tuesday. This company perhaps had one of the best responses to its earnings report on ...
Read Full Story »
money

Acadia Pharmaceuticals Jumps on Incredible Earnings

When Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) released its third-quarter earnings report after the markets closed on Monday, it said it had a net loss of $0.49 per share and $5.3 ...
Read Full Story »